For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250610:nRSJ0858Ma&default-theme=true
RNS Number : 0858M Quadrise PLC 10 June 2025
Certain of the information contained within this announcement is deemed by the
Company to constitute inside information as stipulated under The Market Abuse
Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit)
Regulations 2018. Upon the publication of this announcement via a Regulatory
Information Service ("RIS"), this inside information is now considered to be
in the public domain.
10 June 2025
Quadrise plc
("Quadrise", "QED" or the "Company")
Business Update
Quadrise plc (AIM: QED), the technology company focused on the decarbonisation
of shipping and heavy industry through deployment of low emission fuels and
biofuels, is pleased to provide an update covering progress on its key
projects.
Marine
The expected bilateral agreements between MSC and Cargill, and Cargill and
Quadrise, to initiate the commercial-scale marine trials are now in near final
form and are expected to be concluded soon. Following signature, the trial
equipment will be installed and commissioned at the MAC(2) site in Antwerp,
ahead of the commercial-scale marine trials commencing in Q3 2025.
Quadrise continues to make strong progress in building strategic partnerships
with additional potential customers, aimed at accelerating the
commercialisation of bioMSAR™ and MSAR®. The Company intends to utilise its
facilities at MAC(2) to service these opportunities, as well as establishing
similar supply points in other major marine bunker hubs.
Morocco
The planned commercial trial with OCP to establish MSAR® supply in the
Mediterranean continues to progress. Following relocation to an alternative
production line and associated kiln by OCP, the Company has deployed all
necessary trial equipment to site. To commence the 30-day paid trial, Quadrise
is awaiting approval from the original equipment manufacturer of the kiln and
burner system ("OEM"), which is expected to be received in Q3 2025, with the
trial commencing immediately thereafter.
In parallel, Quadrise and the OEM are exploring potential collaboration
opportunities with other industrial clients.
Americas
In Panama, excellent progress continues to be made for our trial with Sparkle
Power SA. Trial equipment and chemicals have been shipped to site, with the
trial now expected to start during Q3 2025. This will be the first test for
Quadrise on a MAN 4-stroke diesel engine, expanding our application experience
with this significant engine manufacturer. A successful trial would be
expected by the Company to lead to a Fuel Supply Agreement with a supplier and
to facilitate discussions with other regional power producers.
US Low Carbon Fuels
Quadrise is now awaiting delivery of a new batch of oil samples from Valkor's
Primary Project Site ('PPS') at Asphalt Ridge, Utah, USA as the previous
samples tested were deemed unrepresentative of Valkor's expected final oil
output. Once testing of these samples has been positively concluded, marketing
of MSAR® and bioMSAR(TM) fuels in the USA can then commence.
Quadrise now expects to deliver a smaller 600bpd Multifuel Manufacturing Unit
("MMU") to the PPS in Q3 2025, with the US$75k per quarter technology transfer
fee payable by Valkor to Quadrise commencing from the date of delivery.
bioMSAR™ and bioMSAR™ Zero development
Quadrise continues to advance several joint development and commercial
discussions and testing with potential partners and customers to deliver
cleaner fuels at a lower cost than alternatives.
Andy Morrison, Chair of Quadrise, commented:
"Quadrise has continued to make progress throughout 2025 to date. Whilst some
developments have taken longer than originally anticipated, we are more
convinced than ever in the strength of our technology, the scale of the
opportunity, and our ability to successfully deliver on our strategy.
"We enter the next quarter with real momentum and expect to achieve several
important operational milestones which will bring us significantly closer to
commercial deployment and long-term value creation for our shareholders."
For further information please contact:
Quadrise Plc +44 (0)20 7031 7321
Andy Morrison, Chairman
Jason Miles, Chief Technology Officer
Nominated Adviser
Cavendish Capital Markets Limited +44 (0)20 7220 0500
Ben Jeynes
Katy Birkin
George Lawson
Joint Brokers
Shore Capital Stockbrokers Limited +44 (0)20 7408 4090
Toby Gibbs, Harry Davies-Ball (Corporate Advisory)
Fiona Conroy (Corporate Broking)
VSA Capital Limited +44 (0)20 3005 5000
Andrew Raca (Corporate Finance)
Andrew Monk (Corporate Broking)
Public & Investor Relations
Tavistock Communications (Financial PR & IR) +44 (0) 20 7920 3150
Simon Hudson
Nick Elwes
Ruairi Millar
BLUE Communications Limited (Marine & Trade PR)
Rhys Thomas +44 (0)7595 227750
Sam Deacon +44 (0)7527 558846
About Quadrise
Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels
and biofuels, providing innovative solutions to lower energy costs, pollution
and greenhouse gas emissions today for the global power generation, shipping,
industrial and oil industries.
Learn more at: www.quadrise.com
(https://url.avanan.click/v2/___http:/www.quadrise.com/___.YXAxZTpzaG9yZWNhcDphOm86ZTExYWNjYWQ1Yzk5OGYyZTE4OWEwOGU1NmFiNTQ4YTA6NjpkZGJjOmQ4MjM1YWVlZWFiNTI3MmQ1NTg5ZmEzMDE2NGMyYWI3OWQwNmQ3ZGQxNGM3MThlZThkZmNjMjAxZTdjMGU1N2Q6cDpGOk4)
Follow us on social media:
LinkedIn: @Quadrise Plc
(https://url.avanan.click/v2/___https:/uk.linkedin.com/company/quadrise-international-ltd___.YXAxZTpzaG9yZWNhcDphOm86YzA0NmU2YmUyODVhZGE2Zjk4OWY3M2UwZmJjM2YwMWM6Njo3NjdjOjhhYzQ1NzFmN2ZlMjI3OWQ5YjBjNjBhZGEzZTkwMjlhZjUzOWIzMmE0N2EyOTlkZjQxOTlhOGM2Yjg5MDhkYTE6cDpGOk4)
X: @QuadrisePlc
(https://url.avanan.click/v2/___https:/x.com/QuadrisePlc___.YXAxZTpzaG9yZWNhcDphOm86YzA0NmU2YmUyODVhZGE2Zjk4OWY3M2UwZmJjM2YwMWM6NjphMzJiOjlkNjA5MmRmNjg2OTQxNWE4ZDFhYWIxOWRiZjk5MDAxMjc4Njg0Mjg3YjllZWEwMWQ4OTg2ZmE2ZDdiOTY1ODc6cDpGOk4)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END UPDGZGGVNLVGKZM